<DOC>
	<DOCNO>NCT00067184</DOCNO>
	<brief_summary>The purpose study examine difference fetal neurobehavior peak ( 2 hour oral dose ) vs. trough ( 2 hour oral dose ) maternal plasma methadone level .</brief_summary>
	<brief_title>Fetal Neurobehavioral Development Methadone Maintained Pregnancies</brief_title>
	<detailed_description>This study examine difference fetal neurobehavior peak ( 2 hour oral dose ) vs. trough ( 2 hour oral dose ) plasma methadone level . Anecdotal clinical observation suggest fetal activity increase trough methadone level decrease peak methadone level , yet understand utero methadone exposure affect fetal neurobehavioral state development .</detailed_description>
	<mesh_term>Opioid-Related Disorders</mesh_term>
	<mesh_term>Methadone</mesh_term>
	<criteria>Actively enrol pregnant patient CAP SA treatment . Maternal age 1840 year Single intrauterine fetus Estimated gestational age 32 week DSMIV criterion opioid dependence accord emodule SCID Daily methadone maintenance stable dose great week Concurrent DSMIV axis I diagnosis would preclude informed consent procedure ( i.e. , schizophrenia , major depression ) confound study outcome ( e.g. , Alcohol Dependence ) Presence serious medical psychiatric illness require chronic medication intervention ( i.e. , HIV infection ) may confound data interpretation Evidence preterm labor Evidence prescription drug use ( e.g. , antidepressant , tranquilizer ) Presence major congenital fetal malformation Recent use ( last month ) illicit drug ( e.g. , cocaine , marijuana ) base self report positive onTrak urine drug toxicology time actograph session Split methadone dose schedule</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>40 Years</maximum_age>
	<verification_date>February 2013</verification_date>
	<keyword>methadone</keyword>
	<keyword>fetus</keyword>
</DOC>